Aceto Corporation (ACET): Price and Financial Metrics

Aceto Corporation (ACET): $2.16

0.08 (-3.57%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add ACET to Watchlist
Sign Up

Industry: Chemicals

Industry

B

Ranked

#72 of 81

in industry

ACET Price/Volume Stats

Current price $2.16 52-week high $7.50
Prev. close $2.24 52-week low $1.10
Day low $2.14 Volume 416,300
Day high $2.21 Avg. volume 1,639,155
50-day MA $2.49 Dividend yield N/A
200-day MA $2.06 Market Cap 177.45M

ACET Stock Price Chart Interactive Chart >


Aceto Corporation (ACET) Company Bio


Aceto Corporation sources, markets, sells, and distributes pharmaceutical intermediates and active ingredients, finished dosage form generics, nutraceutical products, agricultural protection products, and specialty chemicals. The company was founded in 1947 and is based in Port Washington, New York.


ACET Latest News Stream


Event/Time News Detail
Loading, please wait...

ACET Latest Social Stream


Loading social stream, please wait...

View Full ACET Social Stream

Latest ACET News From Around the Web

Below are the latest news stories about ADICET BIO INC that investors may wish to consider to help them evaluate ACET as an investment opportunity.

Adicet Reports Third Quarter 2023 Financial Results and Provides Business Updates

REDWOOD CITY, Calif. & BOSTON, November 08, 2023--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today reported financial results and operational highlights for the third quarter ended September 30, 2023.

Yahoo | November 8, 2023

Adicet Bio to Present at the 2023 Jefferies London Healthcare Conference

REDWOOD CITY, Calif. & BOSTON, November 07, 2023--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced that Chen Schor, President and Chief Executive Officer, will present at the 2023 Jefferies London Healthcare Conference being held from November 14-16, 2023 in London.

Yahoo | November 7, 2023

Adicet Bio Announces Poster Presentation Highlighting ADI-001 Data at the 65th American Society of Hematology (ASH) Annual Meeting

REDWOOD CITY, Calif. & BOSTON, November 02, 2023--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced the acceptance of a poster presentation at the upcoming 65th American Society of Hematology (ASH) Annual Meeting to be held in San Diego, CA from December 9-12, 2023.

Yahoo | November 2, 2023

Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

REDWOOD CITY, Calif. & BOSTON, October 31, 2023--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced it granted an inducement award on October 31, 2023.

Yahoo | October 31, 2023

Adicet Bio Announces Poster Presentation at the Upcoming 2023 Molecular Targets and Cancer Therapeutics Conference

REDWOOD CITY, Calif. & BOSTON, October 04, 2023--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced a poster presentation at the upcoming 2023 International Conference on Molecular Targets and Cancer Therapeutics hosted by the American Association for Cancer Research, the National Cancer Institute, and the European Organisation for Research and Treatment of Cancer to be held in Bos

Yahoo | October 4, 2023

Read More 'ACET' Stories Here

ACET Price Returns

1-mo 5.37%
3-mo -35.14%
6-mo 51.05%
1-year -61.50%
3-year -83.41%
5-year N/A
YTD 14.29%
2023 -78.86%
2022 -48.89%
2021 24.48%
2020 34.71%
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!